EUCAIM is pleased to announce the signing of two significant Memoranda of Understanding (MoUs) and a Data Share Agreement (DSA), marking a milestone in collaborative efforts to advance cancer research in Europe.
Memorandum of Understanding with EOSC4Cancer and GDI
EUCAIM has signed two MoU, one each with EOSC4Cancer and the Genomic Data Infrastructure (GDI), with the goal of stimulating mutually beneficial exchanges to advance Life Sciences research in Europe, with a specific focus on cancer research.
EOSC4Cancer is a project designed to make a diverse array of cancer-related data accessible. This includes data from genomics, imaging, medical, clinical, environmental, and socio-economic sources. The project aims to enhance and use federated and interoperable systems to securely identify, share, process, and reuse FAIR data across borders. The well-curated datasets provided by EOSC4Cancer will be essential for reproducible and robust analytics and computational methods, including machine learning and artificial intelligence. The project encompasses five use cases that cover the entire patient journey, from cancer prevention and diagnosis to treatment.
The GDI project aims to enhance access to genomic and related phenotypic and clinical data to advance research, policymaking, and healthcare throughout Europe. By unlocking a network of over one million genome sequences, GDI will provide significant opportunities for transnational and multi-stakeholder actions in personalized medicine. This includes applications in cancer, common, rare, and infectious diseases. Additionally, the project will offer access to a reference genome collection representing the European population, known as the Genome of Europe.
For EUCAIM, these partnerships will enable coordinated efforts towards the discovery, access, and sharing of cancer-related research data.
Data Share Agreement with INCISIVE
In addition to the MoUs, EUCAIM has signed a DSA with the INCISIVE project. This agreement outlines the terms and conditions for sharing, managing, and accessing the INCISIVE Data after its completion.
This agreement ensures the continued availability and enhancement of INCISIVE’s valuable data resources, supporting ongoing cancer research and technological development within the EUCAIM framework.
These key partnerships underscore EUCAIM’s commitment to fostering collaboration and innovation in cancer research. EUCAIM is excited about the potential of these collaborations to drive significant advancements in cancer research and looks forward to the positive impact these partnerships will have on the scientific community and patients across Europe.